Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy

Table 2 Relationship between NLR-ALBI grade and clinicopathological features of patients with hepatocellular carcinoma

Index		Groups			X²/ F value	P value
Index		Score = 0	Score = 1	Score = 2	X²/ F value	P value
Age	< 60yrs	36	44	26	0.011	0.994
Age	≥ 60yrs	13	16	9	0.011	0.994
HBsAg	Positive	9	19	6	3.712	0.156
HBsAg	Negative	40	41	29	3.712	0.156
Cirrhosis	Yes	11	28	12	6.942	0.031
Cirrhosis	No	38	32	23	6.942	0.031
Child-Pugh score	A	47	57	27	10.795	0.005
Child-Pugh score	B	2	3	8	10.795	0.005
Differentiation	Low	10	22	13	4.066	0.131
Differentiation	Medium to High	39	38	22	4.066	0.131
AFP	< 400	36	36	17	5.504	0.064
AFP	≥ 400	13	24	18	5.504	0.064
Number of tumors	Single	43	56	27	5.302	0.071
Number of tumors	Multiple	6	4	8	5.302	0.071
Tumor size (cm)	< 5 cm	30	15	4	26.286	< 0.001
Tumor size (cm)	≥ 5 cm	19	45	31	26.286	< 0.001
TNM grade	I	31	23	6	18.339	< 0.001
TNM grade	II-III	18	37	29	18.339	< 0.001
TBIL (µmol/L)		14.25 ± 7.45	13.96 ± 5.28	17.55 ± 7.03	3.761	0.026
ALB (g/L)		42.39 ± 2.74	41.04 ± 4.19	37.31 ± 3.01	22.659	< 0.001
PLT (S)		138.53 ± 69.34	165.07 ± 76.90	167.03 ± 101.64	1.865	0.165
ALT (U/L)		46.21 ± 25.99	50.46 ± 37.62	65.01 ± 37.31	4.459	0.013
AST (U/L)		47.06 ± 26.90	50.87 ± 41.71	57.07 ± 35.15	0.807	0.448
PT (x 10⁹)		12.79 ± 1.65	13.07 ± 1.43	13.63 ± 1.85	2.833	0.062
Scr (µmol/L)		73.16 ± 14.41	70.40 ± 16.29	69.90 ± 15.97	0.588	0.557
CEA (µmol/L)		2.07 ± 1.65	3.98 ± 13.07	2.20 ± 1.99	0.825	0.440
Hospital Duration (D)		18.57 ± 6.81	21.80 ± 8.62	23.31 ± 7.05	4.368	0.014

ISSN: 1471-230X